The Food and Drug Administration (FDA) approved Moderna and Pfizer’s COVID-19 vaccines for booster shot use for adults in the U.S., the agency announced Friday,

The announcement was made just two months after the FDA first rejected the White House’s plan to administer booster shots to all adults the week of Sept. 20. FDA Acting Commissioner Janet Woodcock approved the booster without holding the usual public meeting to review the data, and the Centers for Disease Control and Prevention (CDC) will meet Friday afternoon to discuss the authorization, according to the FDA press release.

“Throughout the course of the COVID-19 pandemic, the FDA has worked to make timely public health decisions as the pandemic evolves. COVID-19 vaccines have proven to be the best and highly effective defense against COVID-19,” Woodcock said in the press release.

“Authorizing the use of a single booster dose of either the Moderna or Pfizer-BioNTech COVID-19 vaccine for individuals 18 years of age and older helps to provide continued protection against COVID-19, including the serious consequences that can occur, such as hospitalization and death,” Woodcock added.

Pfizer and Moderna’s COVID-19 boosters were previously approved for individuals 65 years old and older, high-risk individuals 18 to 64 years old and adults with frequent exposure to the virus, according to the press release.

“The FDA has determined that the currently available data support expanding the eligibility of a single booster dose of the Moderna and Pfizer-BioNTech COVID-19 vaccines to individuals 18 years of age and older,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in the press release.

“Streamlining the eligibility criteria and making booster doses available to all individuals 18 years of age and older will also help eliminate confusion about who may receive a booster dose and ensure booster doses are available to all who may need one,” Marks added.

Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact licensing@dailycallernewsfoundation.org

Harry Wilmerding

Share
Published by
Harry Wilmerding

Recent Posts

President Donald Trump’s Schedule for Friday, November 20, 2026

Schedule Summary: President Donald Trump will hold a policy meeting at the White House, host…

28 minutes ago

Judge Permanently Bars California From Enforcing Its Mask Ban and ID Rules on ICE and Other Federal Officers

A federal judge has permanently barred California from enforcing its laws banning masks and requiring…

7 hours ago

California Subpoenas Nvidia Over Whether Chips or Secrets Reached China, Citing ‘Bright Red Flags’ in Huang Scandal

California Attorney General Rob Bonta served Nvidia with an investigative subpoena Thursday, probing whether its…

7 hours ago

Appeals Court Won’t Rehear McIver’s Bid to Toss ICE Assault Charges, a Day After She Told Mullin ‘You Are Killing People’

The full Third Circuit refused to reconsider a ruling that lets federal assault charges against…

7 hours ago

Judge Holds Denver ICE Officials in Contempt for Re-Arresting a Detainee Moments After His Court-Ordered Release

A federal judge in Denver held ICE officials in contempt for re-arresting a man on…

8 hours ago

2028 Is Looking Like 2016 but Upside Down

The two parties' presidential lineups look a lot like those of the 2015-16 cycle —…

8 hours ago